prof. dr. Bart Lambrecht
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Bart.Lambrecht@UGent.be
- ORCID iD
-
0000-0003-4376-6834
Show
Sort by
-
- Journal Article
- A1
- open access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
-
- Miscellaneous
- open access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
-
- Journal Article
- A1
- open access
RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity
-
- Journal Article
- A1
- open access
The pathology of asthma : what is obstructing our view?
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
Biology of lung macrophages in health and disease
-
- Journal Article
- A1
- open access
GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141
-
- Journal Article
- A1
- open access
The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency : daily practice performance in a tertiary university hospital
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
The Charcot-Leyden crystal protein Galectin-10 is not a major determinant of human regulatory T-cell function